Adhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials.

scientific article published on 28 January 2015

Adhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JBM.B.33366
P698PubMed publication ID25631281

P50authorAndreas LendleinQ39897127
P2093author name stringS Zhou
F Jung
M Walter
S Dietze
C Tschöpe
S Braune
M Groß
S Rutschow
P2860cites workIncidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stentsQ28174787
Use of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugsQ28191375
ImageJ for microscopyQ28253317
Platelet alpha-granulesQ28267795
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stentsQ28287931
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound studyQ30450312
The Residual Platelet Aggregation after Deployment of Intracoronary Stent (PREDICT) score.Q33303244
SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI StudyQ33614699
Platelet dense granules: structure, function and implications for haemostasis.Q33686166
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytesQ34321308
Numerical and experimental evaluation of platelet deposition to collagen coated surface at low shear rates.Q34480163
Current status of prosthetic bypass grafts: a reviewQ34557587
Platelets in atherothrombosisQ34986345
The catastrophe revisited: blood compatibility in the 21st CenturyQ36103108
Prosthetic vascular grafts: wrong models, wrong questions and no healingQ36906021
Surface chemistry influences implant biocompatibilityQ37130897
Clinical utility of the PFA-100.Q37392164
Contemporary platelet function testingQ37690764
Quality standards for sample collection in coagulation testingQ38016382
New anti-platelet agents: the end of resistance?Q38048538
New concepts in the design of drug-eluting coronary stentsQ38082647
Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelializationQ38092061
Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.Q38097973
Human platelet spreading on substrata of known surface chemistryQ41508540
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyQ41968141
Platelet adhesion to polyurethane urea under pulsatile flow conditionsQ42154444
UN targets top killersQ45775396
Guidelines for the laboratory investigation of heritable disorders of platelet functionQ45872104
Poly(ethylene glycol) grafting to poly(ether imide) membranes: influence on protein adsorption and thrombocyte adhesion.Q45927471
Coronary artery disease: Platelet activity: an obstacle for successful PCI.Q45995580
Antiplatelet therapy: Personalized medicine for clopidogrel resistance?Q46045433
Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermiaQ46730289
In vitro and in vivo evaluation of blood coagulation activation of polyvinyl alcohol hydrogel plus dextran-based vascular graftsQ46863918
Plasma-deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition.Q51082748
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.Q51093369
Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials?Q52877848
Multivalent grafting of hyperbranched oligo- and polyglycerols shielding rough membranes to mediate hemocompatibilityQ56978997
Degradable, Multifunctional Cardiovascular Implants: Challenges and HurdlesQ56979608
P433issue1
P921main subjectcoronary artery diseaseQ844935
P304page(s)210-217
P577publication date2015-01-28
P1433published inJournal of Biomedical Materials Research Part BQ6294852
P1476titleAdhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials.
P478volume104

Reverse relations

cites work (P2860)
Q47942458Comment on: "Hemocompatibility of Superhemophobic Titania Surfaces".
Q51617071Effect of temperature on platelet adherence.
Q47616227Hemocompatibility of hyaluronan enhanced linear low density polyethylene for blood contacting applications.
Q53171635Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1.
Q91270600Kinetic study of NTPDase immobilization and its effect of haemocompatibility on polyethylene terephthalate
Q53115720Platelet activation and erythrocyte lysis during brief exposure of blood to pathophysiological shear stress in vitro.
Q47929189Response to "Correspondence Concerning Hemocompatibility of Superhemophobic Titania Surfaces".
Q48923498Strategy for the hemocompatibility testing of microparticles
Q40059372The effect of ventricular assist device-associated biomaterials on human blood leukocytes.
Q88944330Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications

Search more.